Information Provided By: 
Fly News Breaks for August 23, 2016
PHG, RMD
Aug 23, 2016 | 07:12 EDT
As previously reported, Jefferies analyst Anthony Petrone downgraded ResMed (RMD) to Underperform from Hold, noting that the firm's survey and expert calls indicate that those in the field see the company's AirSense10 as still "best-in-class," but Philips' (PHG) Dream has closed the gap while being priced at a discount. Lower Medicare rates that just became effective are pressuring private rates and are seen leading to further consolidation and price pressure, the analyst added. Petrone cut his price target on ResMed shares to $58 from $60.
News For RMD;PHG From the Last 2 Days
